Hepatectomy
================
Oscar J. Ponce & Eddy Lincango
18/11/2020

## Summary of forest plots - *Donors Patients*

### Supplementary Figure 1

<details>

<summary><b>Show figure</b> - Difference in mean total operative time
(min) after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/operativetime1-1.svg)<!-- -->

</details>

### Supplementary Figure 2

<details>

<summary><b>Show figure</b> - Difference in mean total operative time
(min) after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/operativetime2-1.svg)<!-- -->

</details>

### Supplementary figure 3

<details>

<summary> <b>Show figure</b> - Difference in mean blood loss (mL) after
RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/blood_loss_1-1.svg)<!-- -->

</details>

### Supplementary figure 4

<details>

<summary><b>Show figure</b> - Difference in mean blood loss (mL) after
RLDRH versus ODRH </summary>

<img src="hepatectomy_files/figure-gfm/blood_loss2-1.svg" width="14400" />

</details>

### Supplementary figure 5

<details>

<summary><b>Show figure</b> - Difference in mean peak ALT levels (IU/L)
after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/alt1-1.svg)<!-- -->

</details>

### Supplementary figure 6

<details>

<summary><b>Show figure</b> - Difference in mean peak ALT levels (IU/L)
after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/alt2-1.svg)<!-- -->

</details>

### Supplementary figure 7

<details>

<summary><b>Show figure</b> - Difference in mean peak AST levels (IU/L)
after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/ast1-1.svg)<!-- -->

</details>

### Supplementary figure 8

<details>

<summary><b>Show figure</b> - Difference in mean peak AST levels (IU/L)
after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/ast2-1.svg)<!-- -->

</details>

## Summary of forest plots - *Recipient Patients*

</details>

### Supplementary figure 9

<details>

<summary><b>Show figure</b> - Difference in mean blood loss (mL) after
RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/blood_ODRH_recipient-1.svg)<!-- -->

</details>

### Supplementary figure 10

<details>

<summary><b>Show figure</b> - Difference in mean ALT peak levels (IU/L)
after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/alt_ODRH_recipient-1.svg)<!-- -->

</details>

### Supplementary figure 11

<details>

<summary><b>Show figure</b> - Difference in mean AST peak levels (U/L)
afterRLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/ast_ODRH_recipient-1.svg)<!-- -->

</details>

# Overall1

![](hepatectomy_files/figure-gfm/overall_continuous_donor1-1.svg)<!-- -->

### Supplementary figure 9

<details>

<summary><b>Show figure</b> - Difference in mean peak total bilirubin
levels (mg/dL) after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin1-1.svg)<!-- -->

</details>

### Supplementary figure 10

<details>

<summary><b>Show figure</b> - Difference in peak total bilirubin levels
(mg/dL) after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin2-1.svg)<!-- -->

</details>

### Supplementary figure 11

<details>

<summary><b>Show figure</b> - Difference in mean pain scores (VAS) after
RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/pain2-1.svg)<!-- -->

</details>

<details>

<summary> Supp Fig 12: RLDRH versus ODRH - Difference in mean pain
scores (VAS) at day 0-1 </summary>

<p>

![](hepatectomy_files/figure-gfm/pain3_analysis-1.svg)<!-- -->

![](hepatectomy_files/figure-gfm/pain2_followup1-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Supp Fig 13: RLDRH versus ODRH - Difference in pain scores
(VAS) at day 2-3 </summary>

<p>

![](hepatectomy_files/figure-gfm/pain2_followup2-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Supp Fig 14: RLDRH versus ODRH - Difference in pain scores
(VAS) at day greater than 3 </summary>

<p>

![](hepatectomy_files/figure-gfm/pain2_followup3-1.svg)<!-- -->

</p>

</details>

<br />

### Supplementary figure 15

<details>

<summary><b>Show figure</b> - Difference in mean length of hospital stay
(days) after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/hospital1-1.svg)<!-- -->

</details>

### Supplementary figure 16

<details>

<summary><b>Show figure</b> - Difference in mean length of hospital stay
(days) after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/hospital2-1.svg)<!-- -->

</details>

# Overall2

![](hepatectomy_files/figure-gfm/overall_continuous_donor2-1.svg)<!-- -->

### Figure 16

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo I-II at 30 days after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/LADRH_complication1-1.svg)<!-- -->

</details>

### Figure 17

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo III-IV at 30 days after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/LADRH_complication2-1.svg)<!-- -->

</details>

### Figure 18

<details>

<summary><b>Show figure</b> - Risk of postoperative Clevien-Dindo
complications I-II at 30 days after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/ODRH_complication1-1.svg)<!-- -->

</details>

### Figure 19

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo III-IV at 30 days after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/ODRH_complication2-1.svg)<!-- -->

</details>

## Summary of forest plots - *Recipient Patients*

### Figure 20

<details>

<summary><b>Show figure</b> - Difference in mean length of hospital stay
(days) after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/hospitalstay_LADRH_recipient-1.svg)<!-- -->

</details>

### Figure 21

<details>

<summary><b>Show figure</b> - Difference in mean length of hospital stay
(days) after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/hospitalstay_ODRH_recipient-1.svg)<!-- -->

</details>

### Figure 25

<details>

<summary><b>Show figure</b> - Difference in mean peak total bilirubin
levels after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin_ODRH_recipient-1.svg)<!-- -->

</details>

### Figure 26

<details>

<summary><b>Show figure</b> - Mortality risk at 30 days after RLDRH
versus LADRH</summary>

![](hepatectomy_files/figure-gfm/mortality_LADRH-1.svg)<!-- -->

</details>

### Figure 27

<details>

<summary><b>Show figure</b> - Mortality risk at 30 days after RLDRH
versus ODRH</summary>

![](hepatectomy_files/figure-gfm/mortality_ODRH_recipient-1.svg)<!-- -->

</details>

### Figure 28

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo I-II at 30 days after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/complciationsI_LADRH_recipient-1.svg)<!-- -->

</details>

### Figure 29

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo I-II at 30 days after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/complicationsI_ODRH_recipient-1.svg)<!-- -->

</details>

### Figure 30

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo III-IV at 30 days after RLDRH versus LADRH</summary>

![](hepatectomy_files/figure-gfm/complicationsIII_LADRH_recipient-1.svg)<!-- -->

</details>

### Figure 31

<details>

<summary><b>Show figure</b> - Risk of postoperative complications
Clevien-Dindo III-IV at 30 days after RLDRH versus ODRH</summary>

![](hepatectomy_files/figure-gfm/complicationsIII_ODRH_recipient-1.svg)<!-- -->

</details>
